Crossbow Therapeutics

Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of a biotechnology company intended to enhance the quality of life for individuals suffering from cancer. Crossbow Therapeutics is based in Cambridge, MA and was founded in 2021. Its last reported valuation was $125 million in Jul 2023. It has raised $198 million across 2 recorded rounds; the latest was a $30.3 million early-stage round in Sep 2025.

Last reported valuation
$125.0M
Oct 2026
Priced at
—
Total raised
$198.3M
Last round
Early Stage VC
Sep 2025
How much has Crossbow Therapeutics raised?
$198.3Macross 2 recorded rounds · Mar 2023 – Sep 2025

Most recently, Crossbow Therapeutics raised $30.3M in its Early Stage VC (Sep 2025).

Free account
More of Crossbow Therapeutics with a free account
  • ·The complete investor list: 13 names
  • ·Watch Crossbow Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Crossbow Therapeutics round by round

2 rounds
Sep 2025Early Stage VC$30.3MSEC filing▮
17 investors participated
Mar 2023Early Stage VC$37.6MSEC filing▮
15 investors participated

How much has Crossbow Therapeutics raised?

Crossbow Therapeutics has raised $198 million in total; 2 of its rounds are on record. The largest on record was a $37.6 million early-stage round in Mar 2023; the most recent was a $30.3 million early-stage round in Sep 2025.

Crossbow Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently in Sep 2025 ($30.3 million sold to 17 investors).

Crossbow Therapeutics investors

13 investors are on record for Crossbow Therapeutics, including Mirae Asset Capital, Arkin Capital, Pfizer Ventures and Eli Lilly and Company Foundation. The early-stage round in Sep 2025 drew 17 investors.

For fundraisers
Raising for a company like Crossbow Therapeutics?

13 investors have backed Crossbow Therapeutics.

See all 13 investors →

Frequently asked about Crossbow Therapeutics

How much has Crossbow Therapeutics raised?
Crossbow Therapeutics has raised $198.3M in total across 2 recorded funding rounds.
When was Crossbow Therapeutics's last funding round?
Crossbow Therapeutics's most recent recorded round was Early Stage VC in Sep 2025, raising $30.3M.